Clinical Trial Update: KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for KSV01 injection in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and non-Hodgkin lymphoma; trial status is recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• KSV01

Snippet

Sponsor: TCRx Therapeutics Co.Ltd | Conditions: Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL) | Phase 1 | Status: RECRUITING